These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12850518)

  • 1. Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay.
    Hara S; Kimura H; Hoshino Y; Hayashi N; Negoro T; Okumura A; Kajita Y; Sakuma T; Nakayama T; Hosoya M; Tomoda A; Morisima T
    Brain Dev; 2003 Aug; 25(5):367-9. PubMed ID: 12850518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subacute sclerosing panencephalitis: combined treatment with interferon alpha and intraventricular ribavirin].
    del Toro-Riera M; Macaya-Ruiz A; Raspall-Chaure M; Tallada-Serra M; Pasqual-López I; Roig-Quilis M
    Rev Neurol; 2006 Mar 1-15; 42(5):277-81. PubMed ID: 16538590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.
    Hosoya M; Mori S; Tomoda A; Mori K; Sawaishi Y; Kimura H; Shigeta S; Suzuki H
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4631-5. PubMed ID: 15561836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trial of intraventricular ribavirin and interferon-alpha combination therapy for subacute sclerosing panencephalitis (SSPE) in Japan].
    Tomoda A; Nomura K; Shiraishi S; Miike T; Hamada A; Hosoya M
    No To Hattatsu; 2003 Jul; 35(4):321-6. PubMed ID: 12875209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.
    Hosoya M; Shigeta S; Mori S; Tomoda A; Shiraishi S; Miike T; Suzuki H
    Antimicrob Agents Chemother; 2001 Mar; 45(3):943-5. PubMed ID: 11181386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
    Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
    J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable outcomes of interferon-α and ribavirin treatment for a male with subacute sclerosing panencephalitis.
    Sonoda Y; Sonoda M; Yonemoto K; Sanefuji M; Taira R; Motomura Y; Ishimura M; Torisu H; Kira R; Kusuhara K; Sakai Y; Ohga S
    J Neuroimmunol; 2021 Sep; 358():577656. PubMed ID: 34304142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy and prognosis in subacute sclerosing panencephalitis].
    Hosoya M
    Nihon Rinsho; 2007 Aug; 65(8):1483-6. PubMed ID: 17695288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subacute sclerosing panencephalitis (SSPE)].
    Hosoya M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1047-50. PubMed ID: 22277474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis.
    Tomoda A; Shiraishi S; Hosoya M; Hamada A; Miike T
    Pediatr Neurol; 2001 Jan; 24(1):54-9. PubMed ID: 11182282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis: an update.
    Gutierrez J; Issacson RS; Koppel BS
    Dev Med Child Neurol; 2010 Oct; 52(10):901-7. PubMed ID: 20561004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo.
    Takahashi T; Hosoya M; Kimura K; Ohno K; Mori S; Takahashi K; Shigeta S
    Antiviral Res; 1998 Jan; 37(1):29-35. PubMed ID: 9497070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serial ¹⁸FDG-PET study of a patient with SSPE who had good prognosis by combination therapy with interferon alpha and ribavirin.
    Ohya T; Yamashita Y; Shibuya I; Hara M; Nagamitsu S; Kaida H; Kurata S; Ishibashi M; Matsuishi T
    Eur J Paediatr Neurol; 2014 Jul; 18(4):536-9. PubMed ID: 24679544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
    Gupta E; Dar L; Singh S; Behari M; Broor S
    Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon in the treatment of subacute sclerosing panencephalitis.
    Fayad MN; Yamout BI; Mroueh S
    J Child Neurol; 1997 Nov; 12(8):486-8. PubMed ID: 9430312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti SSPE drugs].
    Hosoya M
    Nihon Rinsho; 2012 Apr; 70(4):625-8. PubMed ID: 22568144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Effect of Favipiravir (T-705) against Measles and Subacute Sclerosing Panencephalitis Viruses.
    Hashimoto K; Maeda H; Miyazaki K; Watanabe M; Norito S; Maeda R; Kume Y; Ono T; Chishiki M; Suyama K; Sato M; Hosoya M
    Jpn J Infect Dis; 2021 Mar; 74(2):154-156. PubMed ID: 32863356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man.
    Gagnon A; Bouchard RW
    Arch Neurol; 2003 Aug; 60(8):1160-1. PubMed ID: 12925376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments.
    Schmitz KS; Handrejk K; Liepina L; Bauer L; Haas GD; van Puijfelik F; Veldhuis Kroeze EJB; Riekstina M; Strautmanis J; Cao H; Verdijk RM; GeurtsvanKessel CH; van Boheemen S; van Riel D; Lee B; Porotto M; de Swart RL; de Vries RD
    J Virol; 2024 Mar; 98(3):e0187423. PubMed ID: 38329336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.
    Tomoda A; Nomura K; Shiraishi S; Hamada A; Ohmura T; Hosoya M; Miike T; Sawaishi Y; Kimura H; Takashima H; Tohda Y; Mori K; Kato Z; Fukushima A; Nishio H; Nezu A; Nihei K
    Brain Dev; 2003 Oct; 25(7):514-7. PubMed ID: 13129596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.